House OKs Bills on ACA, Drug Prices
The House this week pushed through a host of new health care bills aimed at supporting the Affordable Care Act and… Read more
HEOR Feature
Featured
NASH Drugs Could Face Payer Roadblocks
While therapies for nonalcoholic steatohepatitis (NASH) aren't expected to reach the market until a couple years yet, the drugs could face challenges… Read more
Tufts’ Chambers Highlights AMCP Presentation
Tufts Medical Center's James Chambers recently offered another look inside his presentation at the Academy of Managed Care Pharmacy's (AMCP) March… Read more
ICER Says J&J’s Spravato is Overpriced
Johnson & Johnson's new therapy to treat resistant depression, Spravato, is overpriced, according to the Institute for Clinical and Economic… Read more
